EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Bausch Health's Enterprise Value is $23,334 Mil.
Bausch Health's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2022 was $384 Mil. Therefore, Bausch Health's EV-to-FCF for today is 60.77.
The historical rank and industry rank for Bausch Health's EV-to-FCF or its related term are showing as below:
BHC'
s EV-to-FCF Range Over the Past 10 Years
Min: 14.72 Med: 33.04 Max: 377.33
Current: 61.19
During the past 13 years, the highest EV-to-FCF of Bausch Health was 377.33. The lowest was 14.72. And the median was 33.04.
BHC's EV-to-FCF is ranked worse than 81.86% of 485
companies
in the Drug Manufacturers industry
Industry Median: 21.03
vs BHC: 61.19
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2022-08-13), Bausch Health's stock price is $6.01.
Bausch Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $0.120. Therefore, Bausch Health's PE Ratio for today is 50.08.
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bausch Health EV-to-FCF Distribution
For the Drug Manufacturers industry and Healthcare sector, Bausch Health's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Bausch Health's EV-to-FCF falls into.
Bausch Health EV-to-FCF Calculation
Bausch Health's EV-to-FCF for today is calculated as:
Bausch Health's current Enterprise Value is $23,334 Mil.
Bausch Health's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $384 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bausch Health (NYSE:BHC) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Bausch Health's PE Ratio for today is calculated as:
Bausch Health's share price for today is $6.01.
Bausch Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.120.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Bausch Health EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Bausch Health's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Bausch Health Companies Inc develop, manufacture and market, primarily in the therapeutic areas of eye-health, gastroenterology and dermatology, a broad range of branded pharmaceuticals, generic and branded generic pharmaceuticals, over-the-counter products and medical devices, which are marketed directly or indirectly in approximately 100 countries. The company's business segments are Bausch + Lomb, Salix, International Rx, Ortho Dermatologics and Diversified Products with maximum revenue from Bausch + Lomb segment.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.19(3.06%) Volume: 6,581,631 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:BHC has been successfully added to your 
